chrisvoncsefalvay/vaers-outcomes huggingface dataset:
H1N1 vaccination administered at approximately 9am on 12/8/09. Mother reported that around 8:30 rash that covered entire body. Pediatrician was called and mother was instructed to administer 1 tsp of Benadryl liquid at that time. Mother states rash gone in the morning of 12/9/09.
I received a PNEUMOVAX shot on Monday afternoon 4/27 and was well until approx. midnight (8hrs after shot). I woke during the night with a very painful, sore arm. I took ALEVE. For the next 2 days the painful arm was so bad, I couldn't lift my arm over head or use it to reach out straight to hold the steering wheel. On the third night I had a 101 degree fever which lasted 8 hrs. Then after the fever, I developed a rush 2 inches below the injection site. It looked like I had been slapped there. My painful arm felt better after 5 days, but it took over a week and a half for it to completely go away. I also had low energy for an entire week. I reported to my doctor. They said to report to  you.
2 days p/ 1st vax  SOB, 10 days SOB to ER,  wheeze lt base, CXR - streaks in base, 2 days p/ 2nd  shot 3/29/99 SOB and cough
Arm at injection site and band-aid was wet; She felt she didn't get all of the dose; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCHARGE (Arm at injection site and band-aid was wet) and ACCIDENTAL UNDERDOSE (She felt she didn't get all of the dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Nov-2021, the patient experienced VACCINATION SITE DISCHARGE (Arm at injection site and band-aid was wet) and ACCIDENTAL UNDERDOSE (She felt she didn't get all of the dose). On 02-Nov-2021, ACCIDENTAL UNDERDOSE (She felt she didn't get all of the dose) had resolved. At the time of the report, VACCINATION SITE DISCHARGE (Arm at injection site and band-aid was wet) outcome was unknown.            No concomitant medications were reported No treatment drugs were reported
On Friday 7/8/22, 1 day after receiving the vaccination, patient stated she had experienced fever, chills, body aches. On Saturday, the area was red and warm to touch.
Breathing difficulty, pressure/tightness in chest.  Monitored during visit to ER at hospital,  No procedures documented. Lab work: Complete Blood and Covid - 19 test, Chest Xray and EKG.
Patient came in for Pfizer first dose accompanied with father. Patient was very anxious and nervous prior to vaccine fighting and screaming in chair but was forced by dad and held down for vaccine. 1104 vaccine was given and at 1111 dad states " he says he has a headache" Patient was taken to gurney VS taken and placed in recumbent position and given juice and observed for 20 minutes. at 1131 dad states "are we good to go?" Dad was educated on s/sx of anaphylactic reaction such as cough, difficulty swallowing, SOB, flush, and to go to nearest ER if any arise. Father verbalized understanding, patient left AxOx4 speaking in full complete sentences able to follow this writers direction with strong steady gait accompanied by father.
Itching around vaccination site, as well as some swelling and possibly a "knot". Warm to the touch and a slight rash broke out.
02/09/2001 ear infection, fever, head pain. 2/23/01 fever and coughing and irritable, screaming. 3/2 still sick, ear infection and eye infection. 4/2 boil at site of injection, constipated, no bowel movement.
Patient had shooting pain in neck, headaches, trouble breathing(SOB), and hives. Patient went to the doctor today 10/30/18 and received a steroid pack.
shingles; Information has been received regarding a case in litigation from a lawyer concerning a female patient of unknown age. Her medical history, concurrent conditions and concomitant medications were not reported.      On an unspecified date in 2015, the pt was vaccinated with a dose of zoster vaccine live(ZOSTAVAX) by a pharmacist for the long-term prevention of shingles and zoster-related conditions (Strength, dose, route of administration, lot # and expiration date were not reported).         Subsequently to Plaintiff's zoster vaccine live(ZOSTAVAX) inoculation, Plaintiff was treated by a healthcare provider for shingles for which the pt was hospitalized (No dates reported). As a direct and proximate result of Plaintiff's use of the zoster vaccine live(ZOSTAVAX), Plaintiff had and would continue suffering ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and would continue to suffer such losses, and damages in the future.    The outcome of herpes zoster was reported as not recovered.     The reporter considered herpes zoster to be related to Zoster Vaccine Live(ZOSTAVAX).
MYOCARDITIS; This spontaneous report received from a consumer via a company representative via social media post concerned a female of unspecified age, race and ethnic origin. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received Covid-19 vaccine ad26.cov2.s (series 1) (suspension for injection, route of admin not reported, batch number: Unknown and expiry: unknown) dose, start therapy date were not reported. 1 total, administered for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot number. No concomitant medications were reported.  On an unspecified date, the patient experienced myocarditis. The action taken with Covid-19 vaccine ad26.cov2.s was not applicable. The outcome of myocarditis was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20211203875 -JANSSEN COVID-19 VACCINE Ad26.COV2.S- Myocarditis. This event(s) is considered unassessable. The event(s) has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
I had the normal symptoms? chills, fever, and headache for about 1.5 days. However, my tonsils started becoming extremely red and sore the next day.  Specifically, the left side, which is the side of the injection. The area, on the outside of my mouth,  where my tonsils are, on the left side, hurt when pressed on. It?s right under my jaw on the side. Not a doctor, but perhaps swollen lymph nodes? Apparently, the shot only causes swollen lymph nodes under the armpit? It?s weird bc the right side doesn?t hurt, just the side where  I was injected. As this isn?t a listed effect, I wanted to mention this! It was too coincidental that this happened right after the vaccine, so I am pretty positive this is what is was from.
Patient returned to clinic stating was losing body hair after second twinrix injection.  Has appointment with Dr. for further evaluation.  Also states was taking herbal medications and had switched regular meds to generic during this time also.
Red arm with 6-7cm red hard site reaction with peripheral swelling, mild pruritus, and pain Similiar to an acute cellulitis x 1 week
This spontaneous report was received from a certified medical assistant referring to an unspecified number of patients (reported as about 15) of unknown age and gender. The patients' pertinent medical history, drug reactions/allergies, concurrent conditions and concomitant medications were not reported. On unknown dates, the patients were vaccinated with improperly stored doses of VARIVAX lot # M032493, expiration date 06-JUL-2018 for prophylaxis (dose, and route were not reported). No adverse effect reported. A product quality complaint (PQC) was not involved. Additional information has been requested.
Site: Pain at Injection Site-Mild, Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Mild, Additional Details: patient came in to report injection site redness and swelling, previous pfizer doses. moderna booster
Initial case received from a health care professional, who was the patient, on 12 March 2012. A 67-year-old male patient received a left deltoid intramuscular injection of FLUZONE, sanofi pasteur Inc. lot number UT481AB, on 31 October 2011. The patient, also a cardiologist, did not report any past medical history; however, the patient took concomitant medication, COZAAR for the past eight years. The patient denied any illness at time of vaccination, denied any known drug allergies, and denied adverse event following prior vaccinations. On a day in November 2011, one week after vaccination, the patient experienced hand/face swelling and burning and developed a rash over his entire body that was biopsied as Erythrodermic Psoriasis, which persists to date. He had lost control of body temperature and experienced generalized itching and shedding of skin, which made walking difficult. The patient required doctor visit and medication, HUMIRA to treat the adverse event. The patient's outcome was not reported. Documents held by sender: None.
12/29 6 hrs after receiving vaccine arm started hurting and minor body aches 12/30 unable to get out of bed, dizzy, ringing in ears, severe headache/body aches, temp 100.5 12/31 headache and left side of neck swollen and painful
The first vaccine, when I got it, I felt okay at the moment but  then I started feeling like a burning feeling inside; like I was going to be sick. I came home and I had diarrhea really really bad. About a week after the vaccine, I had to go the doctor and get pills for nausea and the diarrhea. It hadn't worked to just take Imodium. It was a phone visit. The pills he gave me were Ondansetron  - and that helped with those symptoms. I had soreness on my arm (left) for two weeks - I couldn't lift my arm. It was very painful. I had a hard time focusing. It was like I was in a brain fog. That lasted for about two weeks. I wasn't 100% at the time I had my second vaccine - I was a little better. Each day I was progressing  mostly - yet sometimes I would feel bad again - it would go in spurts like a teeter totter.
Sudden loss of consciousness several hours after vaccination.  EMT could not revive him.  Physical and EKG were normal just 3 days prior at annual exam.  4/29 Autopsy report states COD as atherosclerotic coronary vascular disease.  Manner of death is natural.  4/29 Autopsy states patient found unresponsive & cyanotic at bottom of ladder with a drill (no malfunction).  ASCVD findings: LAD & circumflex arteries to pinpoint lumen; RCA 80% narrowing; aorta w/ulcerated plaque partly occluding left coronary ostium; previous MI, extensive involving lateral LV w/aneurysmal thinning of ventricular wall.
CHILLS; FATIGUE; FEVER; This spontaneous report received from a consumer via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported) dose was not reported, administered on MAR-2021 for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch/lot number. No concomitant medications were reported. On MAR-2021, the subject experienced chills. On MAR-2021, the subject experienced fatigue. On MAR-2021, the subject experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fatigue, chills and fever was not reported. This report was non-serious.
2 hours, post vax, pt became quite fussy and for the next 12 hours was crying hard, constant, funny and occasional high-pitched scream.
Patient experiencing pain, erythema and swelling at injection site; Patient is experiencing pain, erythema and swelling at injection site of PNEUMOVAX; Patient is experiencing pain, erythema and swelling at injection site of PNEUMOVAX; Vaccine was also administered the subdermal route; This spontaneous report was received from a registered nurse concerning a 46 year old male patient. The patient's concurrent conditions included intravenous drug abuse and hepatitis C. The patient's allergies included Mountain Cedar Tree. The patient's concomitant therapies included piperacillin sodium, tazobactam sodium(ZOSYN) and vancomycin(VANCOMYCIN).   On 27-AUG-2019 the patient was vaccinated with a dose of  pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) lot # S012822 with expiration date of 21-FEB-2021, subdermal for prophylaxis (dose and frequency were not provided).       On 29-AUG-2019, the patient was experiencing pain, erythema and swelling at injection site. The patient sought unspecified medical attention and no laboratory diagnostics or studies were performed. The outcome of injection site swelling, injection site pain and injection site erythema was reported as not resolved. The causality assessment was not provided.
This spontaneous report was received from a physician and refers to a male patient of unknown age. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On an unknown date, the patient was subcutaneously vaccinated with an improperly stored dose of Oka-Merck PROQUAD therapy type rHA (recombinant human albumin), lot # N015622, expiration date 15-NOV-2019 (dose was not reported). The vaccine was reconstituted with sterile diluent (lot# N030413, expiration date 05-JUL-2020). No adverse effect reported. Administered dose of vaccine experienced the temperature excursion between 6 to 14 degrees Fahrenheit for 24 hours. Data logger was involved. There were no previous excursions reported. No product quality complaint (PQC) was involved.
Headaches.  9/27/09 Hospital records received DOS 8/31/09 to 9/2/09. Assessment: Headache. Patient presents with headache. Normal neurological exam.  ICD-9: 784.0 Headache.
patient experienced racing heartbeat, heart pounding sound in ears, chest tightness without shortness of breath., and insomnia.  She stated that the symptoms subsided by morning except her heartbeat was still a little elevated in the morning.  She did not do anything to treat the symptoms and did not seek medical advice.  She contacted me to report her symptoms.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a male patient of unknown age.  No information was provided regarding concomitant medications, concurrent conditions or medical history. On or about 07-JAN-2016, the patient was inoculated with ZOSTAVAX at a pharmacy as recommended for routine adult health maintenance and for the prevention of shingles (lot #, dose and route not provided). The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of shingles. On or about 24-MAY-2016, the patient was treated by a physician for the onset of a blistery rash accompanied by weakened immune symptoms, which was diagnosed as severe herpes zoster, or shingles. The patient was prescribed valacyclovir (VATREX) and tramanolone for management of his painful symptoms. As a direct and proximate result of these malfunctions, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. Causality assessment was related. Additional information has been requested.
2 weeks after Covid-19 Moderna vaccine, I started having severe muscle spasms in left upper arm (shot location), both shoulder areas, neck, and both thighs. Plus knees feel weak.  Moderate fatigue and mild headache.
This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), ASTHENIA (Weakness), DIARRHOEA (diarrhea), OROPHARYNGEAL PAIN (sore throat) and ABDOMINAL PAIN UPPER (stomach ache) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.  Concurrent medical conditions included Cancer (Cancer with radiation). Concomitant products included NAPROXEN, GABAPENTIN, MULTIVITAMIN [VITAMINS NOS] and POTASSIUM for an unknown indication.On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, the patient experienced VOMITING (vomiting), NAUSEA (Nausea), FATIGUE (tiredness) and HEADACHE (headache). On 01-Apr-2021, the patient experienced PAIN IN EXTREMITY (Sore arm), ASTHENIA (Weakness), DIARRHOEA (diarrhea), OROPHARYNGEAL PAIN (sore throat), PAIN (Body Pain), CHILLS (chills) and MYALGIA (muscle aches). On an unknown date, the patient experienced ABDOMINAL PAIN UPPER (stomach ache). On 31-Mar-2021, HEADACHE (headache) had resolved. At the time of the report, PAIN IN EXTREMITY (Sore arm), ASTHENIA (Weakness), DIARRHOEA (diarrhea), OROPHARYNGEAL PAIN (sore throat), ABDOMINAL PAIN UPPER (stomach ache), PAIN (Body Pain), VOMITING (vomiting), NAUSEA (Nausea), CHILLS (chills), MYALGIA (muscle aches) and FATIGUE (tiredness) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant medication includes: Allergy medications.
On 11/19/2012, client reported that left shoulder and left side of neck painful since receiving flu shot.
UPON INITIAL INJECTION, NO REDNESS, NO WARMTH, NO SWELLING NOTED.  DAY AFTER "USUAL" SORENESS FOR INFLUENZA INJECTION, BUT FOLLOWING DAYS HAD INCREASED PAIN TO LEFT SHOULDER.  DISCOMFORT HAS CONTINUED FOR OVER 4 WEEKS.  TENDER UPON PALPATION.  DENIES REDNESS, WARMTH, OR SWELLING.  INCREASED DISCOMFORT UPON MOVEMENT OR RAISING ARM OVER HEAD.  DESCRIBES AS "ACHING."  ADVISED TO SEEK TREATMENT AT PCP NOTED ABOVE.
12/7/22 that evening, I had a sore throat. I had been talking all day and felt it was associated with that. I took 2 home COVID tests which were positive. I was tired with a sore throat. On 12/8/22 at night I had low grade fever, never got higher than 100.8. I had chills for about two to three days. I had a rapid antigen test at the pharmacy on 12/9/22, and it was positive. I had fatigue for a solid week. At one point I had a super mild cough that wasn't even regular, just sporadic, and very mild. I have recovered. I had 2 negative COVID tests, the first one on 12/14/2022.
REMOVED BANDAID AND NOTICED SHE HAD SOME SWELLING, REDNESS AND ITCHING.  WAS OFFERED AN APPOINTMENT ON 4/23/13 FOR EVAL BUT WAS NOT NEARBY - CAME IN TO OFFICE FOR EVAL ON 4/24/13 APPROX 10:20AM - WAS TREATED FOR ALLERGIC REACTION - ICE, ZYRTEC AND KEFLEX (IN CASE AN INFECTION).
area was hot to touch; really red area below where she got her injection; 2&1/2" high and 4" wide; little soreness afterwards; she suspects that the injection was given subcutaneous instead of intramuscular; A spontaneous report was received from a consumer regarding herself, a 65-year-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and suspects the injection was given subcutaneous instead of intramuscular/inappropriate route of vaccination, area was hot to touch/vaccination site warmth, little soreness afterwards, really red area below where she got her injection/vaccination site erythema, and site 2&1/2 inches high and 4 inches wide/vaccination site swelling.  The patient's medical history was not provided. Products known to have been used by the patient were not included.  On 25 Jan 2021, prior to the onset of the events, the patient received the first of two planned doses of mRNA-1273 (Lot number: unknown) intramuscularly in the left arm for prophylaxis of COVID-19 infection.    On 25 Jan 2021, the patient reported that she experienced a little soreness afterward and felt as if the dose was given subcutaneously instead of intramuscularly.  On 05 Feb 2021, approximately 11 days after the patient received the vaccine, she reports that she had warmth, swelling and a raised circle at the injection site.   Treatment information was not provided.   Consent to follow up was obtained.  Action taken with mRNA-1273 was not provided.  The outcome of the events, suspects the injection was given subcutaneous instead of intramuscular, area was hot to touch, little soreness afterwards, really red area below where she got her injection, site 2&1/2 inches high and 4 inches wide, was unknown.; Reporter's Comments: This case concerns a 65-year-old female who had a NS unexpected event of Incorrect route of product administration with associated adverse events of NS unexpected vaccination site warmth and NS expected vaccination site pain, vaccination site erythema, vaccination site swelling. Event onset the same day as first dose mRNA-1273. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
This spontaneous report was received from a physician and a practice manager and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 08-JUN-2016, the patient was vaccinated with improperly stored dose of PNEUMOVAX 23 0.5 ml prefilled syringe (lot # L024132, expiration date: 21-JAN-2017; dose and route were not provided). The vaccine was exposed to following separate temperature excursions: first lasting for 712 hours, with the lowest temperature of 34 degrees Fahrenheit and the second lasting for 168 hours, with the lowest recorded temperature of 32 degrees Fahrenheit. The vaccine was stored in a refrigerator. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Sweating; Flu like symptoms; Chills; Body pain; This spontaneous case was reported by a dentist and describes the occurrence of HYPERHIDROSIS (Sweating), INFLUENZA LIKE ILLNESS (Flu like symptoms), CHILLS (Chills) and MYALGIA (Body pain) in a 33-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ACETAMINOPHEN for an unknown indication.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HYPERHIDROSIS (Sweating), INFLUENZA LIKE ILLNESS (Flu like symptoms), CHILLS (Chills) and MYALGIA (Body pain). At the time of the report, HYPERHIDROSIS (Sweating), INFLUENZA LIKE ILLNESS (Flu like symptoms), CHILLS (Chills) and MYALGIA (Body pain) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided. Treatment medications were unknown. Action taken with mRNA-1273 in response to the events was not applicable.